Drug intelligence / Profile preview

carbon-11 butanol

Development stage
Phase 1
Lead developer
Weill Cornell Medicine
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Carbon-11 butanol is a radiopharmaceutical imaging agent used as a positron emission tomography (PET) tracer. It consists of 1-butanol labeled with the radioactive isotope carbon-11. Unlike many PET tracers that bind to specific receptors or transporters, carbon-11 butanol is a freely diffusible tracer that distributes according to blood flow patterns. It is primarily used in research settings to measure regional cerebral blood flow (rCBF), whole-body perfusion, and more recently, to investigate cerebrospinal fluid (CSF) drainage pathways through the nasal mucosa in the context of Alzheimer's disease. Due to the short half-life of carbon-11 (approximately 20 minutes), it requires an on-site cyclotron for production and is typically used in academic and clinical research settings rather than as a commercially marketed pharmaceutical.

Other names
[11C]-butanol[1-11C]butanolcarbon-11 labeled 1-butanolcarbon11 labeled 1-butanolcarbon 11 labeled 1-butanol[11C]n-butanol[11C]butanol

Beyond the preview

Go deeper on carbon-11 butanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbon-11 butanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call